SciSparc: NeuroThera Labs Announces Initiation of Phase IIb Clinical Trial at Hannover Medical School in Germany for Innovative Treatment of Tourette Syndrome

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/23/2026

1. GOOGL
2. TSLA
3. TXN
4. NOW
5. GOOG
6. CSX
7. IBM
8. KNX
9. AMD
10. INTC

Go back to SciSparc: NeuroThera Labs Announces Initiation of Phase IIb Clinical Trial at Hannover Medical School in Germany for Innovative Treatment of Tourette Syndrome
(NASDAQ: SPRC) Delayed: 6.04 +1.20 (24.79%)
Previous Close $4.84    52 Week High $ 
Open $4.94    52 Week Low $ 
Day High $6.46    P/E N/A 
Day Low $4.89    EPS $ 
Volume 55,103       

(NASDAQ: SPRC) Delayed: 6.04 +1.20 (24.79%)
Previous Close $4.84    52 Week High $ 
Open $4.94    52 Week Low $ 
Day High $6.46    P/E N/A 
Day Low $4.89    EPS $ 
Volume 55,103